{"id":"https://openalex.org/W2595145486","doi":"https://doi.org/10.1182/blood.v108.11.4998.4998","title":"Patterns of Venous Thromboembolism (VTE) Following Monoclonal Gammopathy of Undetermined Significance (MGUS) and Multiple Myeloma (MM) among 4 Million U.S. Veterans.","display_name":"Patterns of Venous Thromboembolism (VTE) Following Monoclonal Gammopathy of Undetermined Significance (MGUS) and Multiple Myeloma (MM) among 4 Million U.S. Veterans.","publication_year":2006,"publication_date":"2006-11-16","ids":{"openalex":"https://openalex.org/W2595145486","doi":"https://doi.org/10.1182/blood.v108.11.4998.4998","mag":"2595145486"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v108.11.4998.4998","doi":"https://doi.org/10.1182/blood.v108.11.4998.4998","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v108.11.4998.4998","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082004555","display_name":"Ola Landgren","orcid":"https://orcid.org/0000-0001-6485-4839","observed_orcids":["https://orcid.org/0000-0001-6485-4839"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ola Landgren","raw_affiliation_strings":["National Cancer Institute, NIH, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, NIH, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009359610","display_name":"Thomas Ray Fears","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas R. Fears","raw_affiliation_strings":["National Cancer Institute, NIH, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, NIH, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029832651","display_name":"Ingemar Turesson","orcid":"https://orcid.org/0000-0002-4115-8010","observed_orcids":["https://orcid.org/0000-0002-4115-8010"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ingemar Turesson","raw_affiliation_strings":["Dept of Medicine, Lund University, Malmo, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Medicine, Lund University, Malmo, Sweden","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046644939","display_name":"Magnus Bj\u00f6rkholm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Magnus Bjorkholm","raw_affiliation_strings":["Hematology Center, Karolinska Institute, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Center, Karolinska Institute, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001522697","display_name":"Sigurdur Yngvi Kristinsson","orcid":"https://orcid.org/0000-0002-4964-7476","observed_orcids":["https://orcid.org/0000-0002-4964-7476"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Sigurdur Y. Kristinsson","raw_affiliation_strings":["Hematology Center, Karolinska Institute, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Center, Karolinska Institute, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088770490","display_name":"Gloria Gridley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gloria Gridley","raw_affiliation_strings":["National Cancer Institute, NIH, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, NIH, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019329822","display_name":"Neil E. Caporaso","orcid":"https://orcid.org/0000-0001-7562-4609","observed_orcids":["https://orcid.org/0000-0001-7562-4609"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil E. Caporaso","raw_affiliation_strings":["National Cancer Institute, NIH, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute, NIH, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.38436556,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"108","issue":"11","first_page":"4998","last_page":"4998"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.052000001072883606,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venous-thromboembolism","display_name":"venous thromboembolism","score":0.9980000257492065},{"id":"https://openalex.org/keywords/monoclonal-gammopathy-of-undetermined-significance","display_name":"monoclonal gammopathy of undetermined significance","score":0.9929999709129333},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/veterans","display_name":"veterans","score":0.6140000224113464},{"id":"https://openalex.org/keywords/vte-incidence","display_name":"VTE incidence","score":0.6299999952316284},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.8669999837875366},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.9559999704360962},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":1.0},{"id":"https://openalex.org/keywords/vte-risk-factors","display_name":"VTE risk factors","score":0.628000020980835},{"id":"https://openalex.org/keywords/alcohol-consumption","display_name":"alcohol consumption","score":0.5360000133514404},{"id":"https://openalex.org/keywords/physical-inactivity","display_name":"physical inactivity","score":0.4560000002384186},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.41999998688697815},{"id":"https://openalex.org/keywords/hyperlipidemia","display_name":"hyperlipidemia","score":0.546999990940094},{"id":"https://openalex.org/keywords/thromboprophylaxis","display_name":"thromboprophylaxis","score":0.33899998664855957}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9079971313476562},{"id":"https://openalex.org/C2777250017","wikidata":"https://www.wikidata.org/wiki/Q458138","display_name":"Monoclonal gammopathy of undetermined significance","level":5,"score":0.783503532409668},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.6131159663200378},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6099805235862732},{"id":"https://openalex.org/C2775969662","wikidata":"https://www.wikidata.org/wiki/Q7923600","display_name":"Veterans Affairs","level":2,"score":0.6050492525100708},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5758081674575806},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5576721429824829},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.5499352216720581},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.5222521424293518},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.4946689307689667},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.47854241728782654},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4388664662837982},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3731931447982788},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.36339977383613586},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16012504696846008},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.1218564510345459},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v108.11.4998.4998","doi":"https://doi.org/10.1182/blood.v108.11.4998.4998","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v108.11.4998.4998","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2522002057","https://openalex.org/W1913309327","https://openalex.org/W2159036855","https://openalex.org/W7100785044","https://openalex.org/W2166804832","https://openalex.org/W2980151503","https://openalex.org/W2023189333","https://openalex.org/W114773626","https://openalex.org/W2051305187","https://openalex.org/W2054035291"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"VTE":[2,44,71,75,92,141,176,222,235,275,302,317,349,357,377,391,407,427,496],"risk":[3,42,72,174,272,300,318,392,408,428],"in":[4,45,84,114,237,366,409,445,448,482,502],"MM":[5,82,96,184,196,226,253,290,329,382,500],"patients":[6,185,284,323,334,347,386,411],"has":[7,36],"been":[8,477],"reported":[9,63,365],"to":[10,13,39,341,363],"be":[11,77],"5":[12,294,415],"50-fold":[14],"higher":[15],"than":[16],"the":[17,40,48,173,189,203,206,238,298,315,394,425,471,483],"crude":[18,354,376],"population":[19,139,241],"incidence":[20,142,355,378],"of":[21,28,43,51,91,111,175,191,205,220,273,296,301,345,356,397,404,417,423,485],"0.5":[22,244],"per":[23,245,257,263],"1000":[24,246,258,264],"person-years.":[25],"The":[26,105,137,212,269,353,406],"introduction":[27],"oral":[29],"immunomodulatory":[30],"drugs":[31],"(e.g.":[32],"thalidomide":[33],"and":[34,53,95,103,133,179,183,216,225,251,260,309,328,373,381,419,433,456,459,488],"lenalidomide)":[35],"contributed":[37],"substantially":[38],"increased":[41,307,449,452],"MM,":[46,180],"however":[47],"precise":[49],"contribution":[50],"host":[52],"drug":[54],"related":[55],"mechanisms":[56,444],"remain":[57],"unclear.":[58],"Recently,":[59],"2":[60],"small":[61],"studies":[62],"that":[64,74,364,403],"MGUS":[65,85,94,178,182,199,224,250,286,304,325,333,380,385,410,432,446,487],"is":[66],"associated":[67,498],"with":[68,285,324,499],"an":[69,78],"elevated":[70,375,454],"suggesting":[73],"might":[76],"early":[79,480],"marker":[80],"for":[81,118,140,198,283,322,431,495],"transformation":[83,501],"patients.":[86],"Objective:":[87],"To":[88],"define":[89],"patterns":[90],"following":[93,177,303],"among":[97,223,358,379],"adult":[98],"male":[99,147],"U.S.":[100,124,359],"Veterans.":[101],"Patients":[102],"Methods:":[104],"cohort":[106],"was":[107,168,280,319,361,429],"identified":[108,233],"from":[109],"review":[110],"discharge":[112],"diagnoses":[113],"hospital":[115,164],"medical":[116],"records":[117],"inpatient":[119],"hospitalizations":[120],"at":[121,150,153,420],"142":[122],"nationwide":[123],"Veterans":[125,360],"Affairs":[126],"(VA)":[127],"hospitals":[128],"between":[129],"October":[130],"1,":[131],"1980":[132],"September":[134],"30,":[135],"1996.":[136],"target":[138],"calculation":[143],"included":[144],"all":[145,181],"(N=4,201,697)":[146],"veterans":[148],"hospitalized":[149],"least":[151],"once":[152],"age":[154],"18":[155,255],"or":[156,202],"older":[157],"who":[158,339],"survived":[159],"one":[160],"year":[161],"after":[162,278,312,414],"index":[163],"visit.":[165],"Mean":[166],"follow-up":[167,297,398,418,424],"10":[169],"years.":[170],"For":[171],"estimating":[172],"were":[186,336],"followed":[187],"until":[188],"diagnosis":[190,197,314],"a":[192,195,388],"first":[193,395],"VTE,":[194,267],"cases,":[200],"death,":[201],"end":[204],"observation":[207],"period,":[208],"whichever":[209],"came":[210],"first.":[211],"estimated":[213,270],"cumulative":[214,271,316,390,426],"probability":[215],"95%":[217],"confidence":[218],"intervals":[219],"developing":[221,274],"cases":[227],"used":[228],"Kaplan-Meier":[229],"methods.":[230],"Results:":[231],"We":[232,370],"22,781":[234],"events":[236,481],"entire":[239],"VA":[240],"(crude":[242],"incidence:":[243],"person-years).":[247],"Among":[248,332],"2424":[249],"6282":[252],"patients,":[254,383],"(1.7":[256],"person-years)":[259,265],"83":[261],"(4.2":[262],"developed":[266,348],"respectively.":[268,384],"4":[276],"years":[277,295,311,396,416,422],"MGUS/MM":[279,313],"significantly":[281,308,413],"lower":[282],"(0.47%;":[287],"0.15%\u20130.78%)":[288],"versus":[289],"(1.80%;":[291],"1.37%\u20132.22%).":[292],"After":[293],"relative":[299],"(vs.":[305],"MM)":[306],"8":[310,421],"very":[320],"similar":[321,362,430],"(1.91%;":[326],"0.84%\u20132.96%)":[327],"(2.23%;":[330],"1.62%\u20132.83%).":[331],"there":[335,438],"229":[337],"(9.4%)":[338],"progressed":[340],"MM;":[342],"only":[343],"1":[344],"these":[346],"prior":[350,367],"MM.":[351,405,434,489],"Conclusions:":[352],"population-based":[368],"studies.":[369],"found":[371,492],"4-fold":[372],"8-fold":[374],"had":[387],"low":[389],"during":[393],"but":[399],"over":[400],"time":[401],"approached":[402],"rose":[412],"These":[435],"results":[436],"suggest":[437],"are":[439],"underlying":[440],"gradually":[441],"progressing":[442],"pathogenetic":[443],"reflected":[447],"hypercoagulation,":[450],"e.g.":[451],"angiogenesis,":[453],"IL-6":[455],"TNF":[457],"secretion,":[458],"acquired":[460],"cytogenetic":[461],"lesions":[462],"such":[463],"as":[464,479],"(11;14)":[465],"translocations.":[466],"Interestingly,":[467],"chromosomal":[468],"translocations":[469],"involving":[470],"immunoglobulin":[472],"heavy-chain":[473],"(IgH)":[474],"locus":[475],"have":[476],"proposed":[478],"development":[484],"both":[486],"However,":[490],"we":[491],"no":[493],"evidence":[494],"being":[497],"MGUS.":[503]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2017-03-23T00:00:00"}
